Product Code: 02-HRD-26
From £299.00 Early Bird
Early Bird Deadline: 31/01/2026
Deadline to order: 28/02/2026
HRD testing for Ovarian Cancer (Tissue). This EQA is sponsored.
This EQA is designed for laboratories to test the Homologous Recombination Deficiency (HRD) status, including determining the genomic instability status and to identify variants in Homologous Recombination Repair (HRR) genes in the context of PARP inhibitor therapy for ovarian cancer patients.
CNV, NGS, Panel testing
English, French, German, Italian, Spanish
FFPE
No
June 2026
June - August 2026
December 2026 - January 2027
You can complete purchase on our secure partner site.
The scheme is designed to assess the entire diagnostic pipeline of a laboratory, including sample receipt and processing, analytical processing (genotyping), and reporting (biological and clinical interpretation of the test result) in the context of a clinical referral, as well as reporting clarity, content and clerical accuracy.
Three mock clinical cases with matching samples will be provided.
Two 10µm FFPE sections per case are provided.
Samples are provided as cut sections (rolled scrolls / curls) only – we cannot provide slide mounted materials.
Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
Participants are expected to test the samples according to their routine strategy. For all cases, participants are expected to return a clinical report and complete an online data collection form.
This EQA is supported by an educational grant from AstraZeneca and MSD, fees are subsidised so there is a reduced cost for participants. EMQN acknowledge and thank AstraZeneca and MSD for this support.
Limited to 110 participants, please register early to avoid disappointment. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc).
added wishlist!
View Wishlist
View Wishlist
Express your interest in ''.
